Phase 2 Lung Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged between 18 and 75 years old
- People whose general health and ability to carry out daily activities is rated as fully active or restricted only in physically strenuous activity (this is measured using a standard scale called ECOG, scored 0 or 1)
- People who have been confirmed through laboratory tissue testing to have advanced or metastatic non-small cell lung cancer (a type of lung cancer that has spread)
- People who are able to provide either previously collected or newly collected tumour tissue samples
- People whose cancer has continued to grow or spread after receiving treatment, or who were unable to tolerate previous cancer treatment
- People who have at least one area of cancer that can be measured on scans, according to standard medical guidelines
- People whose doctors estimate they are likely to live for at least 3 more months
- People whose liver, kidneys, and other organs are functioning at an adequate level (confirm with trial site for specific requirements)
Who may not be able to join:
- People who have cancer that has spread to the brain or the lining around the brain, and who are experiencing symptoms from this
- People who have had another type of cancer at any point in the past, or who currently have another cancer alongside their lung cancer
- People who have pressure on the spinal cord caused by cancer that has not yet been treated
- People who have cancer-related pain that is not well managed or controlled
- People who still have significant side effects from previous cancer treatments that have not sufficiently resolved
- People who have a history of a condition involving scarring or inflammation of the lung tissue (interstitial lung disease)
- People who have serious heart or blood vessel conditions (confirm with trial site for specific details)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +0518-81220121
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
ORR assessed by IRC according to RECIST v1.1 s）
Can't join this trial?
Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.